Bronchopulmonary Dysplasia

Recent advances in neonatology and improvements in survival rates for premature infants have brought about a greater incidence of bronchopulmonary dysplasia in this population.

In this book clinicians will find:

• unprecedented scope and depth — a true stand-alone resource
• the progress in understanding lung development — including discoveries in molecular pathways, growth factors, transcription factors, and cell-cell interactions
• information about causation, plus information on how the lungs are injured and how they can be repaired
• review of BPD epidemiology, physiology, and genetics
• a thorough review of drug therapies for management, long-term outcomes, and potential neurological damage associated with prolonged or severe cases of BPD
• emerging therapies for BPD — such as Inhaled Nitrous Oxide, Vitamin A, Antioxidant strategies, and low-dose steroid therapy